Banking quality is a practical litmus test of overall reliability
For most people, semaglutide burping tends to be most common when you start treatment and when increasing your dose, eventually reducing with time as your body gets used to the medication
Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: A systematic review and meta-analysis
Allergic reactions (anaphylaxis), characterized by difficulty breathing, facial swelling, and swallowing, are also serious and need urgent medical help
Your clinician may reduce those doses and teach you how to recognize and treat hypoglycemia
For Zepbound, which is the medication formulated with tirzepatide that has been FDA-approved for weight loss, the initial dosage is 2.5mg per week for the first four weeks, followed by escalation to 5mg once weekly for another four weeks